Hirai H, Matsuda S (September 1999). "Interaction of the C-terminal domain of delta glutamate receptor with spectrin in the dendritic spines of cultured Purkinje cells". Neuroscience Research. 34 (4): 281–287. doi:10.1016/S0168-0102(99)00061-9. PMID10576550. S2CID45794233.
Seeburg PH, Single F, Kuner T, Higuchi M, Sprengel R (July 2001). "Genetic manipulation of key determinants of ion flow in glutamate receptor channels in the mouse". Brain Research. 907 (1–2): 233–243. doi:10.1016/S0006-8993(01)02445-3. PMID11430906. S2CID11969068.
Bhalla T, Rosenthal JJ, Holmgren M, Reenan R (October 2004). "Control of human potassium channel inactivation by editing of a small mRNA hairpin". Nature Structural & Molecular Biology. 11 (10): 950–956. doi:10.1038/nsmb825. PMID15361858. S2CID34081059.
Sommer B, Köhler M, Sprengel R, Seeburg PH (October 1991). "RNA editing in brain controls a determinant of ion flow in glutamate-gated channels". Cell. 67 (1): 11–19. doi:10.1016/0092-8674(91)90568-J. PMID1717158. S2CID22029384.
Cleveland DW, Rothstein JD (November 2001). "From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS". Nature Reviews. Neuroscience. 2 (11): 806–819. doi:10.1038/35097565. PMID11715057. S2CID2050462.
Spreux-Varoquaux O, Bensimon G, Lacomblez L, Salachas F, Pradat PF, Forestier N, et al. (January 2002). "Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients". Journal of the Neurological Sciences. 193 (2): 73–78. doi:10.1016/S0022-510X(01)00661-X. PMID11790386. S2CID25556626.
Kwak S, Kawahara Y (February 2005). "Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis". Journal of Molecular Medicine. 83 (2). Berlin, Germany: 110–120. doi:10.1007/s00109-004-0599-z. PMID15624111. S2CID2255590.
Kawahara Y, Kwak S, Sun H, Ito K, Hashida H, Aizawa H, et al. (May 2003). "Human spinal motoneurons express low relative abundance of GluR2 mRNA: an implication for excitotoxicity in ALS". Journal of Neurochemistry. 85 (3): 680–689. doi:10.1046/j.1471-4159.2003.01703.x. PMID12694394. S2CID5997020.
Kawahara Y, Kwak S (September 2005). "Excitotoxicity and ALS: what is unique about the AMPA receptors expressed on spinal motor neurons?". Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders. 6 (3): 131–144. doi:10.1080/14660820510037872. PMID16183555. S2CID6640926.
Hirai H, Matsuda S (September 1999). "Interaction of the C-terminal domain of delta glutamate receptor with spectrin in the dendritic spines of cultured Purkinje cells". Neuroscience Research. 34 (4): 281–287. doi:10.1016/S0168-0102(99)00061-9. PMID10576550. S2CID45794233.
Seeburg PH, Single F, Kuner T, Higuchi M, Sprengel R (July 2001). "Genetic manipulation of key determinants of ion flow in glutamate receptor channels in the mouse". Brain Research. 907 (1–2): 233–243. doi:10.1016/S0006-8993(01)02445-3. PMID11430906. S2CID11969068.
Bhalla T, Rosenthal JJ, Holmgren M, Reenan R (October 2004). "Control of human potassium channel inactivation by editing of a small mRNA hairpin". Nature Structural & Molecular Biology. 11 (10): 950–956. doi:10.1038/nsmb825. PMID15361858. S2CID34081059.
Sommer B, Köhler M, Sprengel R, Seeburg PH (October 1991). "RNA editing in brain controls a determinant of ion flow in glutamate-gated channels". Cell. 67 (1): 11–19. doi:10.1016/0092-8674(91)90568-J. PMID1717158. S2CID22029384.
Cleveland DW, Rothstein JD (November 2001). "From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS". Nature Reviews. Neuroscience. 2 (11): 806–819. doi:10.1038/35097565. PMID11715057. S2CID2050462.
Spreux-Varoquaux O, Bensimon G, Lacomblez L, Salachas F, Pradat PF, Forestier N, et al. (January 2002). "Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients". Journal of the Neurological Sciences. 193 (2): 73–78. doi:10.1016/S0022-510X(01)00661-X. PMID11790386. S2CID25556626.
Kwak S, Kawahara Y (February 2005). "Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis". Journal of Molecular Medicine. 83 (2). Berlin, Germany: 110–120. doi:10.1007/s00109-004-0599-z. PMID15624111. S2CID2255590.
Kawahara Y, Kwak S, Sun H, Ito K, Hashida H, Aizawa H, et al. (May 2003). "Human spinal motoneurons express low relative abundance of GluR2 mRNA: an implication for excitotoxicity in ALS". Journal of Neurochemistry. 85 (3): 680–689. doi:10.1046/j.1471-4159.2003.01703.x. PMID12694394. S2CID5997020.
Kawahara Y, Kwak S (September 2005). "Excitotoxicity and ALS: what is unique about the AMPA receptors expressed on spinal motor neurons?". Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders. 6 (3): 131–144. doi:10.1080/14660820510037872. PMID16183555. S2CID6640926.
Hirai H, Matsuda S (September 1999). "Interaction of the C-terminal domain of delta glutamate receptor with spectrin in the dendritic spines of cultured Purkinje cells". Neuroscience Research. 34 (4): 281–287. doi:10.1016/S0168-0102(99)00061-9. PMID10576550. S2CID45794233.
Seeburg PH, Single F, Kuner T, Higuchi M, Sprengel R (July 2001). "Genetic manipulation of key determinants of ion flow in glutamate receptor channels in the mouse". Brain Research. 907 (1–2): 233–243. doi:10.1016/S0006-8993(01)02445-3. PMID11430906. S2CID11969068.
Bhalla T, Rosenthal JJ, Holmgren M, Reenan R (October 2004). "Control of human potassium channel inactivation by editing of a small mRNA hairpin". Nature Structural & Molecular Biology. 11 (10): 950–956. doi:10.1038/nsmb825. PMID15361858. S2CID34081059.
Sommer B, Köhler M, Sprengel R, Seeburg PH (October 1991). "RNA editing in brain controls a determinant of ion flow in glutamate-gated channels". Cell. 67 (1): 11–19. doi:10.1016/0092-8674(91)90568-J. PMID1717158. S2CID22029384.
Cleveland DW, Rothstein JD (November 2001). "From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS". Nature Reviews. Neuroscience. 2 (11): 806–819. doi:10.1038/35097565. PMID11715057. S2CID2050462.
Spreux-Varoquaux O, Bensimon G, Lacomblez L, Salachas F, Pradat PF, Forestier N, et al. (January 2002). "Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients". Journal of the Neurological Sciences. 193 (2): 73–78. doi:10.1016/S0022-510X(01)00661-X. PMID11790386. S2CID25556626.
Kwak S, Kawahara Y (February 2005). "Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis". Journal of Molecular Medicine. 83 (2). Berlin, Germany: 110–120. doi:10.1007/s00109-004-0599-z. PMID15624111. S2CID2255590.
Kawahara Y, Kwak S, Sun H, Ito K, Hashida H, Aizawa H, et al. (May 2003). "Human spinal motoneurons express low relative abundance of GluR2 mRNA: an implication for excitotoxicity in ALS". Journal of Neurochemistry. 85 (3): 680–689. doi:10.1046/j.1471-4159.2003.01703.x. PMID12694394. S2CID5997020.
Kawahara Y, Kwak S (September 2005). "Excitotoxicity and ALS: what is unique about the AMPA receptors expressed on spinal motor neurons?". Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders. 6 (3): 131–144. doi:10.1080/14660820510037872. PMID16183555. S2CID6640926.
Vivero M, Doyle LA, Fletcher CD, Mertens F, Hornick JL (Jul 2014). "GRIA2 is a Novel Diagnostic Marker for Solitary Fibrous Tumour Identified through Gene Expression Profiling". Histopathology. 65 (1): 71–80. doi:10.1111/his.12377. PMID24456377. S2CID42812062.